International Journal of Neuropsychopharmacology

Aims & Scope

The central focus of the journal is on research that advances understanding of existing and new neuropsychopharmacological agents including their mode of action and clinical application or provides insights into the biological basis of psychiatric disorders and thereby advances their pharmacological treatment.

Such research may derive from the full spectrum of biological and psychological fields of inquiry encompassing classical and novel techniques in neuropsychopharmacology as well as strategies such as neuroimaging, genetics, psychoneuroendocrinology and neuropsychology.

Emphasis is given to original research (in the form of full-length papers and brief reports), which is of wide interest and clearly advances the field.

Selected review articles and papers that highlight novel trends and perspectives are also considered.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.7
2024	4.50

SJR (SCImago Journal Rank)

Year	Value
2024	1.585

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	130

Journal Rank

Year	Value
2024	2171

Journal Citation Indicator

Year	Value
2024	1322

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,945.00 GBP. Learn more.

Explore journals without APCs for alternative publishing options.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation

  Citation: 995

  Authors: Andre Russowsky, Joao, Bruna, Magdalena Sarah, Brenno Gomes, Felipe

• A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression

  Citation: 744

  Authors: André Russowsky, Mariana, Felipe

• Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

  Citation: 729

  Authors: Felicity, Michael, Olivia, Ashley I.

• Dopamine System Dysregulation in Major Depressive Disorders

  Citation: 612

  Authors: Pauline, Anthony A

• Blood BDNF concentrations reflect brain-tissue BDNF levels across species

  Citation: 585

  Authors: Anders B., Rebecca, Martin A., Christoffer, Anders, Maribel, Gitte M., Susana

• Targeting acetylcholinesterase and butyrylcholinesterase in dementia

  Citation: 508

  Authors: Roger M., Steven G., Albert

• Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior

  Citation: 500

  Authors: Pauline, Karen-Anne, Clara Seira, Gerard, Timothy G., John F.

• Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders

  Citation: 476

  Authors: Jeremy W., Jun-Feng, Ana C., Li, L. Trevor

• A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia

  Citation: 474

  Authors: Neil D., Scot E., Herbert Y., David H.

• Evidence-Based Guidelines and Secondary Meta-Analysis for the Use of Transcranial Direct Current Stimulation in Neurological and Psychiatric Disorders

  Citation: 446

  Authors: Felipe, Mirret M, Kevin, Sandra, Jorge, Marcel, Jerome, Ester Miyuki, Paola, Ganesan, Daniel, Wolnei, Marom, André R, Alejandra, Stefano, Judah, Douglas, Piero F, Maria, Marina, Ana, Roberto M, Mayumi, Anna C, Huiyan

---